CLEC1B and Venous thrombosis: Recently, platelet ITAM receptors C‐type lectin‐like receptor 2 (CLEC‐2) and GPVI have emerged as novel targets in thromboinflammatory diseases, due to the finding that CLEC‐2 interaction with its ligand podoplanin promotes venous thrombosis.98, 99